The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading

Leukemia. 2015 Jan;29(1):241-4. doi: 10.1038/leu.2014.262. Epub 2014 Sep 3.

Authors

O Pozdnyakova¹, S Rodig¹, S Bhandarkar², K Wu², J Thiele³, R Hasserjian⁴

Affiliations

¹ Brigham and Women's Hospital, Boston, MA, USA.
² Sanofi Oncology, Cambridge, MA, USA.
³ University of Cologne, Cologne, Germany.
⁴ Massachusetts General Hospital, Boston, MA, USA.

PMID: 25183285
DOI: 10.1038/leu.2014.262

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Biopsy
Bone Marrow / metabolism*
Bone Marrow / pathology
Clinical Trials as Topic*
Humans
Internationality
Reticulin / metabolism*

Substances

Reticulin